Resveratrol protects against doxorubicin-induced cardiotoxicity in aged hearts through the SIRT1-USP7 axis

Effects of short-term endurance exercise training on acute doxorubicin-induced FoxO transcription in cardiac and skeletal muscle

(2014) Andreas N. Kavazis et al.   JOURNAL OF APPLIED PHYSIOLOGY

Analysis of Skeletal Muscle Gene Expression Patterns and the Impact of Functional Capacity in Patients With Systolic Heart Failure

(2014) Daniel E. Forman et al.   JOURNAL OF CARDIAC FAILURE

Protective effect of resveratrol against doxorubicin-induced cardiac toxicity and fibrosis in male experimental rats

(2014) Manar Hamed Arafa et al.   JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY

Modulating effect of SIRT1 activation induced by resveratrol on Foxo1-associated apoptotic signalling in senescent heart

(2014) Thomas K. Sin et al.   JOURNAL OF PHYSIOLOGY-LONDON

Sirtuin 1 (SIRT1) Activation Mediates Sildenafil Induced Delayed Cardioprotection against Ischemia-Reperfusion Injury in Mice

(2014) Mona Shalwala et al.   PLoS One

Doxorubicin-induced carbonylation and degradation of cardiac myosin binding protein C promote cardiotoxicity

(2014) Baikuntha Aryal et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

SIRT1 mediates the protective function of Nkx2.5 during stress in cardiomyocytes

(2013) Wei Zheng et al.   BASIC RESEARCH IN CARDIOLOGY

Chemosensetizing and cardioprotective effects of resveratrol in doxorubicin- treated animals

(2013) Abdel-Moneim M Osman et al.   Cancer Cell International

SIRT1 activation by curcumin pretreatment attenuates mitochondrial oxidative damage induced by myocardial ischemia reperfusion injury

(2013) Yang Yang et al.   FREE RADICAL BIOLOGY AND MEDICINE

Supervillin-mediated Suppression of p53 Protein Enhances Cell Survival

(2013) Zhiyou Fang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Doxorubicin induces protein ubiquitination and inhibits proteasome activity during cardiotoxicity

(2013) Balindiwe J.N. Sishi et al.   TOXICOLOGY

Sesamin ameliorates doxorubicin-induced cardiotoxicity: Involvement of Sirt1 and Mn-SOD pathway

(2013) Suwen Su et al.   TOXICOLOGY LETTERS

Heart Transplant Survival Outcomes for Adriamycin-Dilated Cardiomyopathy

(2012) Andrew J. Lenneman et al.   AMERICAN JOURNAL OF CARDIOLOGY

Different Effects of Resveratrol on Dose-Related Doxorubicin-Induced Heart and Liver Toxicity

(2012) Jaroslaw Dudka et al.   Evidence-based Complementary and Alternative Medicine

Daunorubicin therapy is associated with upregulation of E3 ubiquitin ligases in the heart

(2012) Balindiwe J N Sishi et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Inhibition of AMP-activated Protein Kinase α (AMPKα) by Doxorubicin Accentuates Genotoxic Stress and Cell Death in Mouse Embryonic Fibroblasts and Cardiomyocytes

(2012) Shaobin Wang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor

(2012) Asaf A Qureshi et al.   Lipids in Health and Disease

Unknown

(2012) Bixi Jian et al.   MOLECULAR MEDICINE

Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in mice through SIRT1-mediated deacetylation of p53

(2011) C. Zhang et al.   CARDIOVASCULAR RESEARCH

Protective effect of caspase inhibition on compression-induced muscle damage

(2011) Bee T. Teng et al.   JOURNAL OF PHYSIOLOGY-LONDON

Recombinant human interleukin-1 receptor antagonist protects mice against acute doxorubicin-induced cardiotoxicity

(2010) Jinzhou Zhu et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Resveratrol attenuates doxorubicin-induced cellular damage by modulating nitric oxide and apoptosis

(2010) Gulperi Oktem et al.   EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY

Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway

(2009) Elizabeth D. Brookins Danz et al.   FREE RADICAL BIOLOGY AND MEDICINE

TNF induction of atrogin-1/MAFbx mRNA depends on Foxo4 expression but not AKT-Foxo1/3 signaling

(2008) Jennifer S. Moylan et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

A therapeutic dose of doxorubicin activates ubiquitin-proteasome system-mediated proteolysis by acting on both the ubiquitination apparatus and proteasome

(2008) Jinbao Liu et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Elevated p53 expression is associated with dysregulation of the ubiquitin-proteasome system in dilated cardiomyopathy

(2008) E. J. Birks et al.   CARDIOVASCULAR RESEARCH

Atrogin-1 ubiquitin ligase is upregulated by doxorubicin via p38-MAP kinase in cardiac myocytes

(2008) Yasuhiro Yamamoto et al.   CARDIOVASCULAR RESEARCH